MPI score assessment of perforation peritonitis patients

Harshawardhan Vidyasagar Saygaonkar (1) , Nerlekar H V (2)
(1) Department of Surgery, Kims, Karad, Maharashtra, India, India ,
(2) Department of Surgery, Kims, Karad, Maharashtra, India, India

Abstract

The most widespread clinical emergency in India is perforation peritonitis. Following improvements in operational procedures, antimicrobial treatments, and care in ICUs, peritonitis control is often very complicated, complicated, and challenging. MPI provides the highest precision of risk-assessment such that specific predictions for patients with peritonitis could be estimated. The objective of this research is to determine the prognosis for perforated peritonitis patients using the peritonitis index from Mannheim. It is also targeted at a) assessing the results in Mannheim peritonitis test perforation cases b) evaluating elevated incidents of perforated peritonitis on the Peritonitis Scale with C) Determining the function of the Mannheim Peritonitis Index in decision-making on peritonitis surgery. This research measured the diagnosis of perforated peritonitis patients utilizing peritonitis score of Mannheim’s Index. In the present study, we observed that the majority of the study subjects were males (65.38%), and many of the cases ranged from the age group of 46-55 years (25%), as well as 36-45 years (23.07%). The majority of the cases had duodenal perforation (42.30%), followed by gastric perforation (28.84%), appendicular perforation (13.46%), filial perforation (9.61%), jejunal (3.8%), colonic perforation (1.9%). We observed that the majority of the study subjects reported the MPI score between 21-29 (46.15%), followed by (38.46%) cases who reported MPI score of more than 29, and 15.38% who reported MPI score less than 21.

Full text article

Generated from XML file

Authors

Harshawardhan Vidyasagar Saygaonkar
Nerlekar H V
drhvnerlekar@yahoo.com (Primary Contact)
Harshawardhan Vidyasagar Saygaonkar, & Nerlekar H V. (2020). MPI score assessment of perforation peritonitis patients. International Journal of Research in Pharmaceutical Sciences, 11(3), 4047–4053. Retrieved from https://ijrps.com/home/article/view/973

Article Details

No Related Submission Found